Realize Therapeutics Corp.
Realize Therapeutics is focused on providing Health Care Practitioners (HCPs) with medical nutrition solutions for their patients suffering from obesity and type 2 diabetes. Realize’s strategy is to develop microbe and endocannabinoid formulations to restore and modulate the human microbiome. We intend to validate our formulations through human clinical trials and commercialize them as branded SmartBiome™ products, exclusively through HCPs in the US and through partners globally.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
About Us
Healthcare practitioner’s offices are becoming overwhelmed with patients who are overweight, obese, pre-diabetic and diabetic (Type-2). Practitioners are frustrated with the lack of results using conventional treatments that come with significant side effects. Patients suffer with poor outcomes while placing a substantial burden on the healthcare system.
Realize’s novel approach is to see these disease symptoms through the lens of a disrupted microbiome. Our proprietary microbes with endocannabinoids provide a new way to transform health.
specific microbes coupled with endocannabinoids and nutrients that modulate microbiome composition
Based upon the work of Dr. William Davis, Realize formulations employ the therapeutic strategy of restoring specific microbes with endocannabinoids and nutrients that yield Microbiome Restoration and Modulation. This provokes endogenous chemical production, particularly oxytocin, and normalizes blood sugar and body weight among many other significant biomarkers.